Vaz-Da-Silva, M., Almeida, L., Falcão, A., Soares, E., et al. (2010). Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study. Clinical therapeutics, 32(1), 179 - 192.

Almeida, L., Vaz-Da-Silva, M., Falcão, A., Soares, E., et al. (2009). Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Molecular Nutrition and Food Research, 53(SUPPL. 1), S7 - S15.

Vaz-Da-Silva, M., Loureiro, A. I., Falcao, A., Nunes, T., et al. (2008). Effect of food on the pharmacokinetic profile of trans-resveratrol. International Journal of Clinical Pharmacology and Therapeutics, 46(11), 564 - 570.

Almeida, L., Falcão, A., Vaz-Da-Silva, M., Nunes, T., et al. (2008). Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. European Journal of Clinical Pharmacology, 64(10), 961 - 966.

Vaz-Da-Silva, M., Loureiro, A. I., Nunes, T., Lopes, C., et al. (2008). Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-O-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg: Randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Drugs in R and D, 9(6), 435 - 446.

Almeida, L., Kashdan, T. B., Nunes, T., Coelho, R., et al. (2008). Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. European Journal of Clinical Pharmacology, 64(6), 575 - 582.

Almeida, L., Azevedo, B., Nunes, T., Vaz-Da-Silva, M., & Soares-Da-Silva, P. (2007). Why healthy subjects volunteer for phase I studies and how they perceive their participation?. European Journal of Clinical Pharmacology, 63(11), 1085 - 1094.